Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pituitary gonadotropin |
Is a |
True |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Adrenocorticotropic hormone |
Is a |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Thyrotrophin |
Is a |
True |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Human growth hormone |
Is a |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Poisoning caused by combination analgesic of undetermined intent |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Accidental corticotrophin poisoning (disorder) |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Intentional corticotrophin poisoning (disorder) |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Corticotrophin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Accidental gonadotrophin poisoning |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Intentional gonadotrophin poisoning |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Gonadotrophin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Accidental somatotrophin poisoning |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Intentional somatotrophin poisoning |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatotrophin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Poisoning caused by somatotropin |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Poisoning by corticotropin |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Poisoning by anterior pituitary hormone |
Causative agent (attribute) |
True |
Anterior pituitary hormone |
Inferred relationship |
Some |
1 |
Poisoning caused by oxytocic agent |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Poisoning by gonadotropin |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Intentional combined analgesic overdose |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Anterior pituitary hormone poisoning NOS |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Oxytocic agent poisoning NOS |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Corticotropin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Product containing melatonin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Corticotrophins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 1.8iu(0.6mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 1.2iu(0.4mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 0.6iu(0.2mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rmc) 24iu(8mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon)+diluent+kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 12iu(4mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 2.4iu(0.8mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 3iu(1mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 5.3 milligram/1 cartridge powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 16iu(5.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rmc) 10iu(3.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rmc) 4iu(1.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 4iu(1.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 12 mg powder for solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 18iu(6mg) powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 36iu(12mg) powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 72iu(24mg) powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 3.6iu(1.2mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 4.2iu(1.4mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 4.8iu(1.6mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 5.4iu(1.8mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 6iu(2mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(epr) 3.33mg/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(epr) 6.66mg/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(epr) 10mg/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatrophic hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Human growth hormone recombinant preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Product containing somatotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Anterior pituitary extract preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Product containing corticotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Product containing somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 10mg/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 10mg/2mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.6mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.2mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 2mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.8mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 2.0mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 13.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.5mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.4mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.2mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 5.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.4mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.6mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.2mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.8mg/unit powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.6mg/unit powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.8mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.44mg/unit powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.8mg/.25mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 1.0mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.4mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Product containing anterior pituitary hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anterior pituitary hormone |
Inferred relationship |
Some |
1 |
Somatropin 12mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 0.6mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 15mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 5.0mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 5mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 10mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 6mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 10.0mg/1.5mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 4mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 8.8mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 13.5mg/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 18mg/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 22.5mg/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin(rbe) 5mg(15iu)/mL injection solution 2mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Bovine growth hormone recombinant preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Sometribove preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Corticotropin 80units/mL in gelatin injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Bovine growth hormone |
Is a |
True |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Somatropin (substance) |
Is a |
True |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Accidental gonadotrophin poisoning |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|
Intentional gonadotrophin poisoning |
Causative agent (attribute) |
False |
Anterior pituitary hormone |
Inferred relationship |
Some |
|